TECX
Tectonic Therapeutic, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Tectonic Therapeutic, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Tectonic is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors. We have developed a proprietary technology platform called GEODe™ to enable the discovery and development of GPCR-targeted biologic medicines that can modify the course of disease, by addressing challenges that have limited the pace of innovation in this field. Our focus is on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life.
Tectonic is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors. We have developed a proprietary technology platform called GEODe™ to enable the discovery and development of GPCR-targeted biologic medicines that can modify the course of disease, by addressing challenges that have limited the pace of innovation in this field. Our focus is on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life.
No other changes.
No other changes.
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Largest filed tie
0
filed ties
Same SIC code · 6
Same SEC industry code: Amgen Inc, Gilead Sciences, Inc., Biogen Inc. and 3 more; of Tectonic Therapeutic, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Amgen Inc, Gilead Sciences, Inc., Biogen Inc. and 3 more; of Tectonic Therapeutic, Inc.'s 6 closest co-movers, none share that code.
Tectonic Therapeutic, Inc.
18.97
−0.01 · −0.03%
post 18.97 0.00%
+2.51%
vs ±17.1% implied · ×0.15
shaded = implied · ▲▼ = realized
Tall tick = annual report · Source: EDGAR
Bull2
Bear2
| Manager | Value | % base | |
|---|---|---|---|
| FMR | $97.3M | 19.98% | +0.49% |
| TCG Crossover | $41.4M | 8.50% | 0.00% |
| Standard Life Aberdeen | $39.3M | 8.06% | 0.00% |
| BlackRockindex-like | $29.7M | 6.09% | +0.26% |
| First Light | $27.5M | 5.65% | +23.62% |
| Manager | Value | % base | |
|---|---|---|---|
| FMR | $97.3M | 19.98% | +0.49% |
| TCG Crossover | $41.4M | 8.50% | 0.00% |
| Standard Life Aberdeen | $39.3M | 8.06% | 0.00% |
| BlackRockindex-like | $29.7M | 6.09% | +0.26% |
| First Light | $27.5M | 5.65% | +23.62% |
Expected move
No implied move.